|
Drug-induced liver Injury (DILI) remains a major problem for drug development and a clinical concern after marketing. We need new understanding, and a path forward to solve the problems. This academic-industry-government international conference will discuss new findings and thinking about DILI, including presentations by experts in clinical hepatology, toxicology, and other fields, and lively discussions with all registrants.
The program is co-sponsored by the Food and Drug Administration/Center for Drug Evaluation and Research (FDA/CDER), Critical Path Institute (C-Path), and Pharmaceutical Research and Manufacturers of America (PhRMA).
The progarm is endorsed by the National Institutes of Health (NIH) and the Drug-Induced Liver Injury Network (DILIN).
When
Wednesday, March 20, 2013 8:00 AM - Thursday, March 21, 2013 4:00 PM
Eastern Time
Where
Marriott Inn & Conference Center
University of Maryland
University College
3501 University Blvd.
East Hyattsville, Maryland 20783
Fees
Event Registration
Government or Academia
$300.00
Industry
$600.00
Speaker Complimentary
View Event Summary
View Event Agenda
RSVP
Tuesday, March 19, 2013
|
